| Literature DB >> 32158850 |
Hussein Elgohary1, Ahmed M Nawar2, Ahmed Zidan3, Ahmed A Shoulah2, Mohamed T Younes2.
Abstract
OBJECTIVE: To evaluate functional and aesthetic outcomes of the reconstruction of soft-tissue defects of the heel with microsurgical techniques using a free radial forearm flap and an anterolateral thigh flap. PATIENTS AND METHODS: The study included 25 patients, 15 males and 10 females, with a mean age of 34.3 ± 10.4 years, with soft-tissue defects of the heel. Of them, 11 patients whose defects were of size between 5 and 10 cm in their largest dimension were treated using a free radial forearm flap, and 14 patients whose defects were of size larger than 10 cm in their largest dimension were treated using a free anterolateral thigh flap.Post-operatively, avoidance of weight-bearing and walking was required for 8 to 10 weeks. At the end of the follow-up, all patients underwent functional, aesthetic and sensation evaluation in addition to assessment of patient satisfaction.Entities:
Keywords: Aesthetic outcome; Free flap; Functional; Reconstruction; Soft-tissue defect of heel
Year: 2018 PMID: 32158850 PMCID: PMC7061545 DOI: 10.1016/j.jpra.2018.10.008
Source DB: PubMed Journal: JPRAS Open ISSN: 2352-5878
Figure 1Anterolateral thigh flap.
Figure 2Free radial forearm flap.
Patients’ characteristics.
| Number | Percentage | |
|---|---|---|
| Manual worker | 13 | 52% |
| Employee | 6 | 24% |
| Student | 3 | 12% |
| House wife | 3 | 12% |
| None | 14 | 56% |
| Diabetes mellitus | 8 | 32% |
| Viral hepatitis C | 3 | 12% |
| Right | 15 | 60% |
| Left | 10 | 40% |
| Trauma | 14 | 56% |
| Neuropathic | 8 | 32% |
| Neoplasia | 3 | 12% |
| Tissue loss with granulation tissue | 13 | 42% |
| Gangrenous soft tissue | 4 | 16% |
| Necrotic tissue | 5 | 20% |
| Malignant ulcer | 2 | 8% |
| Residual malignancy | 1 | 4% |
| Associated calcaneal fracture | 4 | 16% |
| Anterolateral thigh | 14 | 56% |
| Radial forearm | 11 | 44% |
Operative and post-operative data.
| RFF | ALTF | |
|---|---|---|
| No. of patients | 11 (44%) | 14 (56%) |
| Op time | 360 ± 25 min | 480 ± 18 min |
| Op blood loss | 450 ± 40 ml | 1200 ± 60 ml |
| Need for blood transfusion | ——– | 2 cases (8%) |
| ICU admission | ——— | ———- |
| Hospital stay | 12 ± 3 days | 18 ± 5 days |
Post-operative complications.
| Complication | RFF (25) | ALTF (25) |
|---|---|---|
| Total flap loss | 1 (4.0) | 1 (4.0) |
| Partial flap loss | 0 (0.0) | 2 (8.0) |
| Bulky flaps | 0 (0.0) | 10 (40.0) |
| Flap ulceration | 1 (4.0) | 2 (8.0) |
| Infection | 2 (8.0) | 4 (16.0) |
| Seroma | 0 (0.0) | 0 (0.0) |
| Haematoma | 0 (0.0) | 1 (4.0) |
| Absent flap sensation | 2 (8.0) | 3 (12.0) |
| Patchy sensory loss | 1 (4.0) | 5 (20.0) |
| Donor site morbidity | ||
| *hypertrophic scar | 1 (4.0) | 2 (8.0) |
| *keloid | 0 (0.0) | 0 (0.0) |
| *hyperpigmentation | 1 (4.0) | 0 (0.0) |
| *contracture | 0 (0.0) | 0 (0.0) |
Mean 2PD at the flap during the follow-up period.
| Type of flap | 6 months | 12 months | 18 months | 24 months | |
|---|---|---|---|---|---|
| 2PD | RFF (11) | ||||
| Mean ± SD | 4.15 ± 0.98 | 3.66 ± 0.59 | 3.35 ± 0.61 | 3.21 ± 0.56a | |
| Median, IQR | 4.8, 3–5 | 4, 3–4.2 | 3, 2.8–4 | 3.5, 2.6–3.6 | |
| ALTF (14) | 3.56 ± 0.75* | 3.15 ± 0.52* | 2.97 ± 0.50a | 2.9 ± 0.49a | |
| Mean ± SD | 3.5, 2.8–4.3 | 3.16, 2.66–3.65 | 2.8, 2.5–3.43 | 2.6, 2.5–3.43 | |
| Median, IQR |
Patients’ satisfaction and aesthetic outcomes.
| Patient's satisfaction | Very satisfied | Satisfied | Poorly satisfied | Unsatisfied |
|---|---|---|---|---|
| No. of patients | —————– | 18 (72%) | 2 (8%) | 5 (20%) |
| Aesthetic outcome | Excellent | Good | Fair | Poor |
| No. of patients | 8 (32%) | 10 (40%) | 3 (12%) | 4 (16%) |
Revised FFI score repeated every 6 months for 2 years during the follow-up period.
| Type of flap | 6 months | 12 months | 18 months | 24 months | |
|---|---|---|---|---|---|
| Pain score % | RFF (11) | 56.55±6.42 | 43.45±4.08 | 34.45±5.18 | 29.73±3.23 |
| Mean±SD | 60, 49-62 | 45, 39-47 | 31, 30-40 | 28, 27-33 | |
| Median, IQR | |||||
| ALTF (14) | 70.93±7.17 | 61.54±5.99 | 48.07±5.22 | 32.86±2.92 | |
| Mean±SD | 76, 63-77 | 57, 56.5-68.5 | 51.5, 42.38-52.6 | 34.5, 29.5-35.5 | |
| Median, IQR | |||||
| Stiffness score % | RFF (11) | 78.84±6.38 | 60.91±3.44 | 38.26±4.31 | 28.29±5.03 |
| Mean±SD | 83, 72.12-85 | 59, 58.5-66 | 41, 34-42.4 | 31, 23.12-33 | |
| Median, IQR | |||||
| ALTF (14) | 80.22±5.4 | 64.98±4.17 | 43.87±5.24 | 34.31±2.85 | |
| Mean±SD | 80.4, 74.75-85.2 | 62, 61.38-69.5 | 44, 38.88-49 | 33.5, 31.85-37.4 | |
| Median, IQR | |||||
| Difficulty score % | RFF (11) | 60.36±4.43 | 48.38±5.33 | 32.64±2.99 | 27.14±2.66 |
| Mean±SD | 63, 56-64 | 44.2, 43.7-54 | 34, 29.5-35.5 | 27.5, 24.5-30 | |
| Median, IQR | |||||
| ALTF (14) | 68.93±4.70 | 50.29±5.99 | 38.69±4.31 | 31.43±5.28 | |
| Mean±SD | 69, 64-73.25 | 50.5, 44.75-56 | 38.5, 34.58-42.9 | 31.5, 26.28-36.5 | |
| Median, IQR | |||||
| Activity limitation score % | RFF (11) | 74.91±6.89 | 50.27±5.29 | 37.45±3.95 | 31.65±4.41 |
| Mean±SD | 72, 68-82 | 54, 45-55 | 36, 34-41.5 | 35, 27-35.5 | |
| Median, IQR | |||||
| ALTF (14) | 81.26±5.90 | 68.14±4.72 | 50.07±3.08 | 43.27±2.11 | |
| Mean±SD | 81.5, 75.23-87 | 65, 64-73.25 | 51, 47-53 | 42, 41.45-45.65 | |
| Median, IQR | |||||
| Social score issue % | RFF (11) | 68.47±4.01 | 51.36±3.14 | 36.59±5.01 | 31.36±3.12 |
| Mean±SD | 68.4, 64.5-72.5 | 53, 48-54 | 36.5, 31.5-41.5 | 29, 28.5-34.5 | |
| Median, IQR | |||||
| ALTF (14) | 78.79±5.25 | 67.5±5.26 | 47.47±6.24 | 38.11±3.58 | |
| Mean±SD | 78.75, 73.88-84 | 67.25, 62.75-73 | 47.5, 41.4-53.43 | 36, 35-42 | |
| Median, IQR | |||||
| Overall score % | RFF (11) | 67.46±6 | 51.18±4.92 | 35.5±5.02 | 29.91±2.69 |
| Mean±SD | 67.3, 61.5-73.5 | 54, 46-55 | 35.5, 30.5-40.5 | 30, 27.5-32 | |
| Median, IQR | |||||
| ALTF (14) | 76.5±4.78 | 62.57±5.4 | 45.93±5.96 | 36.0±3.19 | |
| Mean±SD | 79, 71-81 | 65.5, 57-67.25 | 45.75, 40-52 | 36, 32.88-39.13 | |
| Median, IQR |
Significance between two groups at p ≤0.05
Significance against 6 month follow-up at p ≤0.05 in the same group
Significance against 12 month follow-up at p ≤0.05 in the same group
Significance against 18 month follow-up at p ≤0.05 in the same group